Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat

Epilepsy Research

Volumn 34, Issue 2-3, 1999, Pages 251-269

  Halonen, Toivo ^a   Nissinen, Jari ^a   Pitkänen, Asla ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Amygdala; Antiepileptic drug; Electroencephalogram; Entorhinal cortex; Epilepsy; Hippocampus; Neuronal damage; Piriform cortex

Indexed keywords

1 METHYL 1,2 DIPHENYLETHYLAMINE; AR R 12495AA; REMACEMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; MALE; MAZE TEST; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; SPATIAL MEMORY;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; BODY TEMPERATURE; BRAIN; CARBAMAZEPINE; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PERFORANT PATHWAY; RATS; RATS, WISTAR; STATUS EPILEPTICUS; SWIMMING;

EID: 0032916583     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00122-3     Document Type: Article

References (39)

1. Bannan P.E., Graham D.I., Lees K.R., McCulloch J. Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat. Brain Res. 664:1994;271-275.
2. Barone F.C., Feuerstein G.Z., White R.F. Brain cooling during transient focal ischemia provides complete neuroprotection. Neurosci. Biobehav. Rev. 21:1997;31-44.
3. Black M.A., Tremblay R., Mealing G.A.R., Durkin J.P., Whitfield J.F., Morley P. The desglycinyl metabolite of remacemide hydrochloride is neuroprotective in cultured rat cortical neurons. J. Neurochem. 66:1996;989-995.
4. Bornstein R.A., Pakalnis A., Drake M.E. Jr., Suga L.J. Effects of seizure type and waveform abnormality on memory and attention. Arch. Neurol. 45:1988;884-887.
5. Cereghino J.J. Serum carbamazepine concentration and clinical control. Adv. Neurol. 11:1975;309-330.
6. Cheung H., Wamil A.W., Harris E.W., McLean M.J. Effects of remacemide hydrochloride, its desglycinated metabolite and isomers on sustained repetitive firing in mouse spinal cord cultured neurones. FASEB J. 6:1992;1879.
7. Choi D.W. Methods antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2:1990;105-147.
8. Clark B., Hutchison J.B., Jamieson V., Jones T., Palmer G.C., Scheyer R.D. Potential antiepileptic drugs. Remacemide hydrochloride. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 1995;1035-1044 Raven Press, New York.
9. Clifton G.L., Jiang J.Y., Lyeth B.G., Jenkins L.W., Hamm R.J., Hayes R.L. Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11:1991;114-121.
10. De Lanerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:1989;387-395.
11. Fish B.J. Spehlmann's EEG Primer. 2nd edn:1991;Elsevier, Amsterdam.
12. Halonen T., Nissinen J., Jansen J.A., Pitkänen A. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus. Eur. J. Pharmacol. 299:1996;69-81.
13. Harris E., Stagnitto M., Garske G. et al. Neuroprotection in animals by remacemide, a prodrug for noncompetetive NMDA antagonism with a high therapeutic index. Kamenka J-M., Domino E.F. Multiple Sigma and PCP Ligands: Mechanisms for Neuromodulation and Neuroprotection? 1992;643-653 NPP Books, Ann Arbor, MI.
14. Insausti R., Herrero M.T., Witter M.P. Entorhinal cortex of the rat: cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus. 7:1997;146-183.
15. Lencz T., McCarthy G., Bronen R.A. et al. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and psychopharmacological function. Ann. Neurol. 31:1992;629-637.
16. van Luijtelaar E.L.J.M., Coenen A.M.L. Effects of remacemide and its metabolite FPL 12495 on spike-wave discharges, electroencephalogram and behaviour in rats with absence epilepsy. Neuropharmacology. 34:1995;419-425.
17. Morris R.G.M., Garraud P., Rawlis J.N.P., O′Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature (Lond.). 297:1982;681-683.
18. Moser E., Moser M.-B., Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J. Neurosci. 13:1993;3916-3925.
19. Moser M.-B., Moser E.I., Forrest E., Andersen P., Morris R.G.M. Spatial learning with minislab in the dorsal hippocampus. Proc. Natl. Acad. Sci. USA. 92:1995;9697-9701.
20. Palmer G.C., Clark B., Hutchison J.B. Antiepileptic and neuroprotective potential of remacemide hydrochloride. Drugs Future. 18:1993;1021-1042.
21. Palmer G.C., Cregan E.F., Borrelli A.R., Willett F. Neuroprotective properties of the uncompetetive NMDA receptor antagonist remacemide hydrochloride. Ann. New York Acad. Sci. 765:1995;236-248.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
23. Pitkänen A., Tuunanen J., Halonen T. Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus-induced neuronal damage in the hippocampus and amygdala. Epilepsy Res. 24:1996;29-45.
24. Pitkänen A., Savander V., LeDoux J.E. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci. 20:1997;517-523.
25. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizures. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
26. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 69:1995;831-845.
27. Sechi G.P., Russo A., Rosati G., Mutani R., Monaco F. Distribution of diphenylhydantoin in the brain during experimental status epilepticus of the cat. Epilepsy Res. 1:1987;173-177.
28. Simon R.P., Benowitz N., Hedlund R., Copeland J. Influence of the blood-brain pH gradient on brain phenobarbital uptake during status epilepticus. J. Pharmacol. Exp. Ther. 234:1985;830-835.
29. Sloviter R.S. Epileptic' brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain Res. Bull. 10:1983;675-697.
30. Sloviter R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 235:1987;73-76.
31. Smith D.H., Perri B.R., Raghupathi R., Saatman K.E., McIntosh T.K. Remacemide hydrochloride reduces cortical lesion volume following brain trauma in the rat. Neurosci. Lett. 231:1997;135-138.
32. Stubley-Weatherly L., Harding J.W., Wright J.W. Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats. Brain Res. 716:1996;29-38.
33. Subramaniam S., Donevan S.D., Rogawski M.A. 1,2-Di-phenyl-2-propylamine, a major metabolite of the novel anticonvulsant remacemide hydrochloride, produces a stereoselective block of NMDA receptor currents. Soc. Neurosci. Abstr. 19:1993;717.
34. Subramaniam S., Donevan S.D., Rogawski M.A. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite. J. Pharmacol. Exp. Ther. 276:1996;161-168.
35. Sutherland R.J., Whishaw I.Q., Kolb B.A. Behavioural analysis of spatial localization following electrolytic-, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav. Brain Res. 7:1983;133-153.
36. Swansson L.W. Brain Maps: Structure of the Rat Brain. 1992;Elsevier, Amsterdam.
37. Wamil A.W., Cheung H., Harris E.W., McLean M.J. Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture. Epilepsy Res. 23:1996;1-14.
38. Wieser H.G. Behavioural consequences of temporal lobe resections. Trimble M.R., Bolwig T.G. The Temporal Lobe and the Limbic System. 1992;169-188 Wrightson Biomedical Publishing, Petersfield.
39. Ylinen A.M.A., Miettinen R., Pitkänen A., Gulyas A.I., Freund T., Riekkinen P.J. Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy. Proc. Natl. Acad. Sci. USA. 88:1991;7650-7653.